{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:42:22Z","timestamp":1794613342331,"version":"4.9.1"},"reference-count":34,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100004412","name":"T\u00fcrkiye Bilimler Akademisi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Volcano Corporation"},{"name":"Oxford Biomedical Research Centre"},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2017,5,9]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Early detection of microvascular dysfunction after acute myocardial infarction (AMI) could identify patients at high risk of adverse clinical outcome, who may benefit from adjunctive treatment. Our objective was to compare invasively measured coronary flow reserve (CFR) and hyperaemic microvascular resistance (HMR) for their predictive power of long-term clinical outcome and cardiac magnetic resonance (CMR)-defined microvascular injury (MVI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Simultaneous intracoronary Doppler flow velocity and pressure measurements acquired immediately after revascularisation for AMI from five centres were pooled. Clinical follow-up was completed for 176 patients (mean age 60\u00b110 years; 140(80%) male; ST-elevation myocardial infarction (STEMI) 130(74%) and non-ST-segment elevation myocardial infarction 46(26%)) with median follow-up time of 3.2 years. In 110 patients with STEMI, additional CMR was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The composite end point of death and hospitalisation for heart failure occurred in 17 patients (10%). Optimal cut-off values to predict the composite end point were 1.5 for CFR and 3.0\u2009mm Hg cm<jats:sup>\u22121<\/jats:sup>\u2022s for HMR. CFR &lt;1.5 was predictive for the composite end point (HR 3.5;95%\u2009CI 1.1 to 10.8), but not for its individual components. HMR \u22653.0\u2009mm Hg cm<jats:sup>\u22121<\/jats:sup> s was predictive for the composite end point (HR 7.0;95% CI 1.5 to 33.7) as well as both individual components. HMR had significantly greater area under the receiver operating characteristic curve for MVI than CFR. HMR remained an independent predictor of adverse clinical outcome and MVI, whereas CFR did not.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>HMR measured immediately following percutaneous coronary intervention for AMI with a cut-off value of 3.0\u2009mm Hg cm<jats:sup>\u22121<\/jats:sup> s, identifies patients with MVI who are at high risk of adverse clinical outcome. For this purpose, HMR is superior to CFR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2017-311431","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T20:40:55Z","timestamp":1498768855000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":56,"title":["Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction"],"prefix":"10.1136","volume":"104","author":[{"given":"Guus A","family":"de Waard","sequence":"first","affiliation":[{"name":"Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Fahrni","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douwe","family":"de Wit","sequence":"additional","affiliation":[{"name":"Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Kitabata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Williams","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niket","family":"Patel","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F","family":"Teunissen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"van de Ven","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabahattin","family":"Umman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Knaapen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divaka","family":"Perera","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akasaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sezer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh K","family":"Kharbanda","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"van Royen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"2025091921460350000_104.2.127.1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrcardio.2014.188","article-title":"Intramyocardial haemorrhage after acute myocardial infarction","volume":"12","author":"Betgem","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2025091921460350000_104.2.127.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht100"},{"key":"2025091921460350000_104.2.127.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq299"},{"key":"2025091921460350000_104.2.127.4","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-014-0430-z"},{"key":"2025091921460350000_104.2.127.5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4244\/EIJV9I3A63","article-title":"Effect of pressure-controlled intermittent coronary sinus occlusion (PICSO) on myocardial ischaemia and reperfusion in a closed-chest porcine model","volume":"9","author":"Khattab","year":"2013","journal-title":"EuroIntervention"},{"key":"2025091921460350000_104.2.127.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054374"},{"key":"2025091921460350000_104.2.127.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.759167"},{"key":"2025091921460350000_104.2.127.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60648-1"},{"key":"2025091921460350000_104.2.127.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157233","article-title":"Dissecting the effects of ischemia and reperfusion on the coronary microcirculation in a rat Model of acute myocardial infarction","volume":"11","author":"Hollander","year":"2016","journal-title":"PLoS One"},{"key":"2025091921460350000_104.2.127.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.001786"},{"key":"2025091921460350000_104.2.127.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.07.987"},{"key":"2025091921460350000_104.2.127.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.05.014"},{"key":"2025091921460350000_104.2.127.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.04.029"},{"key":"2025091921460350000_104.2.127.14","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1195"},{"key":"2025091921460350000_104.2.127.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.04.015"},{"key":"2025091921460350000_104.2.127.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.022603"},{"key":"2025091921460350000_104.2.127.17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4244\/EIJV9I2A38","article-title":"Percutaneous coronary intervention increases microvascular resistance in patients with non-ST-elevation acute coronary syndrome","volume":"9","author":"Akdeniz","year":"2013","journal-title":"EuroIntervention"},{"key":"2025091921460350000_104.2.127.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv626"},{"key":"2025091921460350000_104.2.127.19","first-page":"267","article-title":"ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task Force for the management of acute coronary syndromes in patients presenting without persistent ST-Segment elevation of the european Society of Cardiology (ESC)","volume":"2016","author":"Roffi","year":"2015","journal-title":"Eur Heart J"},{"key":"2025091921460350000_104.2.127.20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs215"},{"key":"2025091921460350000_104.2.127.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.006"},{"key":"2025091921460350000_104.2.127.22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000023041.26199.29"},{"key":"2025091921460350000_104.2.127.23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002834"},{"key":"2025091921460350000_104.2.127.24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4070\/kcj.2015.45.3.194","article-title":"Usefulness of hyperemic microvascular resistance index as a predictor of clinical outcomes in patients with ST-Segment elevation myocardial infarction","volume":"45","author":"Jin","year":"2015","journal-title":"Korean Circ J"},{"key":"2025091921460350000_104.2.127.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.11.026"},{"key":"2025091921460350000_104.2.127.26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.112.000168"},{"key":"2025091921460350000_104.2.127.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2014.05.010"},{"key":"2025091921460350000_104.2.127.28","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.80.6.1846"},{"key":"2025091921460350000_104.2.127.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.01.001"},{"key":"2025091921460350000_104.2.127.30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004482"},{"key":"2025091921460350000_104.2.127.31","doi-asserted-by":"crossref","unstructured":"Hassell ME , Bax M , van Lavieren MA , et al . Microvascular dysfunction following ST-elevation myocardial infarction and its recovery over time, is associated with short and long term cardiac function. EuroIntervention 2017 (Epub ahead of print: 21\u00a0Feb 2017).doi:10.4244\/EIJ-D-16-00818","DOI":"10.4244\/EIJ-D-16-00818"},{"key":"2025091921460350000_104.2.127.32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000298"},{"key":"2025091921460350000_104.2.127.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.08.018"},{"key":"2025091921460350000_104.2.127.34","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2015-000238"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-311431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T04:46:11Z","timestamp":1758343571000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-311431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,3]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/heartjnl-2017-311431"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-311431","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/heartjnl-2017-311431.supp1","asserted-by":"subject"}]},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,29]]}}}